nitrous oxide has been researched along with Chronic Disease in 27 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of continuous administration of 50% nitrous oxide in oxygen for reducing pain during flexible fiberoptic bronchoscopy 32 children aged 3-60 months were randomly assigned to an experimental or a control group." | 9.08 | [Bronchial endoscopy under local anesthesia and pain in children. The value of a nitrous oxide-oxygen combination]. ( Dupont, D; Garcia, J; Hayem, C; Roure, P, 1998) |
| "To evaluate the efficacy of continuous administration of 50% nitrous oxide in oxygen for reducing pain during flexible fiberoptic bronchoscopy 32 children aged 3-60 months were randomly assigned to an experimental or a control group." | 5.08 | [Bronchial endoscopy under local anesthesia and pain in children. The value of a nitrous oxide-oxygen combination]. ( Dupont, D; Garcia, J; Hayem, C; Roure, P, 1998) |
| "From May 2001 to December 2006, 256 consecutive patients who underwent a concomitant maze procedure using nitrous oxide-based cryoablation for chronic atrial fibrillation (AF) during cardiac surgery were enrolled." | 3.85 | Impact of ablation duration on rhythm outcome after concomitant maze procedure using cryoablation in patients with persistent atrial fibrillation. ( Jeon, CS; Jeong, DS; Kim, WS; Lee, YT; Park, PW; Sung, K; You, JH, 2017) |
| " Here we compared the therapeutic effects of oral delivery of bovine milk-derived iron-saturated lactoferrin (Fe-bLF), angiogenin, osteopontin (OPN), colostrum whey protein, Modulen IBD (Nestle Healthsciences, Rhodes, Australia), and cis-9,trans-11 conjugated linoleic acid (CLA)-enriched milk fat in a mouse model of dextran sulfate-induced colitis." | 3.83 | Comparative activities of milk components in reversing chronic colitis. ( Haggarty, NW; Kanwar, JR; Kanwar, RK; Krissansen, GW; MacGibbon, AKH; Palmano, KP; Rowan, A; Roy, K; Stathopoulos, S, 2016) |
| "The investigation of gas exchange, central hemodynamics and real oxygen transport has shown expediency of using ether and fluothane as main anesthetic drugs in operations on the lungs in patients with a compensated form of chronic pulmonary respiratory insufficiency." | 3.67 | [Clinico-physiological substantiation of using various methods of anesthesia in operations on the lungs in patients with chronic respiratory insufficiency]. ( Zverev, VV, 1985) |
| "Pancuronium bromide was used as the muscle relaxant." | 2.64 | Althesin and pancuronium in chronic liver disease. ( Adu-Gyamfi, Y; Strunin, L; Ward, ME, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (51.85) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Demas, A | 1 |
| Le Boisselier, R | 1 |
| Simonnet, L | 1 |
| De Menibus-Demas, L | 1 |
| Langlois, V | 1 |
| Cochin, JP | 1 |
| Jeong, DS | 1 |
| You, JH | 1 |
| Jeon, CS | 1 |
| Park, PW | 1 |
| Sung, K | 1 |
| Kim, WS | 1 |
| Lee, YT | 1 |
| Düzenli, U | 1 |
| Bozan, N | 1 |
| Turan, M | 1 |
| Ağırbaş, S | 1 |
| Tekeli, AE | 1 |
| Kıroğlu, AF | 1 |
| Heller, BJ | 1 |
| DeMaria, S | 1 |
| Mendoza, E | 1 |
| Hyman, J | 1 |
| Iloreta, AMC | 1 |
| Lin, HM | 1 |
| Govindaraj, S | 1 |
| Levine, AI | 1 |
| Kolpen, M | 1 |
| Kühl, M | 1 |
| Bjarnsholt, T | 1 |
| Moser, C | 1 |
| Hansen, CR | 1 |
| Liengaard, L | 1 |
| Kharazmi, A | 1 |
| Pressler, T | 1 |
| Høiby, N | 1 |
| Jensen, PØ | 1 |
| Kanwar, JR | 1 |
| Kanwar, RK | 1 |
| Stathopoulos, S | 1 |
| Haggarty, NW | 1 |
| MacGibbon, AKH | 1 |
| Palmano, KP | 1 |
| Roy, K | 1 |
| Rowan, A | 1 |
| Krissansen, GW | 1 |
| Bause, GS | 1 |
| Jevtovic-Todorovic, V | 1 |
| Hartman, RE | 1 |
| Izumi, Y | 1 |
| Benshoff, ND | 1 |
| Dikranian, K | 1 |
| Zorumski, CF | 1 |
| Olney, JW | 1 |
| Wozniak, DF | 1 |
| Lassinger, BK | 1 |
| Kwak, C | 1 |
| Walford, RL | 1 |
| Jankovic, J | 1 |
| Sutton, DN | 1 |
| Poskitt, KR | 1 |
| Kennedy, TL | 1 |
| Gore, LB | 1 |
| Gillman, MA | 1 |
| Lichtigfeld, FJ | 1 |
| Misiewicz, A | 3 |
| Wegiel, A | 1 |
| Takahashi, H | 1 |
| Honjo, I | 1 |
| Naito, Y | 1 |
| Miura, M | 1 |
| Tanabe, M | 1 |
| Hasebe, S | 1 |
| Toda, H | 1 |
| Garcia, J | 1 |
| Roure, P | 1 |
| Hayem, C | 1 |
| Dupont, D | 1 |
| Patel, B | 1 |
| Potter, C | 1 |
| Mellor, AC | 1 |
| Turek, IS | 1 |
| Hanlon, TE | 1 |
| Ward, ME | 1 |
| Adu-Gyamfi, Y | 1 |
| Strunin, L | 1 |
| Baktai, G | 1 |
| Székely, E | 1 |
| Márialigeti, T | 1 |
| Kovács, L | 1 |
| Zverev, VV | 1 |
| Ozenberger, JM | 1 |
| Tarhan, S | 1 |
| Moffitt, EA | 1 |
| Sessler, AD | 1 |
| Douglas, WW | 1 |
| Taylor, WF | 1 |
| Kipsidze, NN | 1 |
| Capidze, GJ | 1 |
| Browne, DR | 1 |
| Rochford, J | 1 |
| O'Connell, U | 1 |
| Jones, JG | 1 |
| Brakensiek, AL | 1 |
| Bergman, NA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The EPigenetic Consequences in Children of Intravenous vs Volatile Anaesthesia for Surgery (EPIVA) - A Randomised, Feasibility Trial[NCT05936853] | 16 participants (Anticipated) | Interventional | 2023-07-31 | Not yet recruiting | |||
| Anesthesia Exposure and Neurodevelopment in Infants and Children: Pediatric Anesthesia & NeuroDevelopment (PANDA) Study[NCT00881764] | 369 participants (Actual) | Observational | 2009-05-31 | Completed | |||
| Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery on Peri-operative Outcomes and Neurocognitive Development in Infants: A Randomized Controlled Trial[NCT02559102] | Phase 3 | 104 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| Randomized Controlled Trial of Nitrous Oxide Analgesia in External Cephalic Version (ECV)[NCT03502915] | Phase 3 | 48 participants (Actual) | Interventional | 2017-01-30 | Completed | ||
| Appendectomy During Pregnancy in General Anesthesia With Perioperative Management Does Not Influence Normal Child Development: 10-year Study[NCT05759351] | 30 participants (Actual) | Observational | 2006-01-01 | Completed | |||
| A Comparison of Functional Magnetic Resonance Imaging (fMRI) Findings in Children With and Without a History of Early Exposure to General Anesthetics[NCT01229514] | 30 participants (Actual) | Observational | 2008-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Anxiety scores will be collected following each version attempt using an 11 point scale (0 being not at all anxious; 10 being extremely anxious), ranging from 0 to 10. Higher scores indicate more anxiety, lower scores indicate less anxiety. If more than one attempt, anxiety scores will be averaged to obtain a single score for the entire procedure. (NCT03502915)
Timeframe: During each version procedure, a total average of up to approximately 30 minutes
| Intervention | score on a scale (Mean) |
|---|---|
| Nitrous Oxide | 4.696 |
| Oxygen | 4.253 |
Pain scores will be collected following each version attempt using an 11 point scale (with 0 being no pain at all; 10 being worst pain imaginable), ranging from 0 to 10. Higher scores indicate more pain, lower scores indicate less pain. If more than one attempt, pain scores will be averaged to obtain a single score for the entire procedure. (NCT03502915)
Timeframe: During each version procedure, a total average of up to approximately 30 minutes
| Intervention | score on a scale (Mean) |
|---|---|
| Nitrous Oxide | 5.486 |
| Oxygen | 5.433 |
Pain scores will be collected following completion of the version using an 11 point scale (0 being no pain at all; 10 being worst pain imaginable), ranging from 0 to 10. Higher scores indicate more pain, lower scores indicate less pain. (NCT03502915)
Timeframe: Immediately Post-procedure, within approximately 15 minutes of final version attempt
| Intervention | score on a scale (Mean) |
|---|---|
| Nitrous Oxide | 1 |
| Oxygen | 0.88 |
Satisfaction will be assessed following the procedure using an 11 point scale (0 being not at all satisfied; 10 being extremely satisfied), ranging from 0 to 10. Higher scores indicate more satisfaction, lower scores indicate less satisfaction. (NCT03502915)
Timeframe: Immediately Post-procedure, within approximately 15 minutes of final version attempt
| Intervention | score on a scale (Mean) |
|---|---|
| Nitrous Oxide | 4.286 |
| Oxygen | 6.920 |
Following the procedure, the obstetric provider performing the procedure will rate the ease of procedure on a 1-10 scale (1 being very easy and 10 being extremely difficult), ranging from 1 to 10. Higher scores indicate more difficulty, lower scores indicate less difficulty. A 10 point scale was used for this outcome, while an 11 point scale was used for the other 4 outcome measures (pain, anxiety, post-procedure pain and satisfaction). (NCT03502915)
Timeframe: Immediately Post-procedure, within approximately 15 minutes of final version attempt
| Intervention | score on a scale (Mean) |
|---|---|
| Nitrous Oxide | 6.136 |
| Oxygen | 6.080 |
2 reviews available for nitrous oxide and Chronic Disease
| Article | Year |
|---|---|
The use of hypnosis in dentistry: a review.
Topics: Analgesia; Anesthesia, Dental; Anesthetics, Inhalation; Behavior Therapy; Chronic Disease; Dental An | 2000 |
The effectiveness and safety of electroconvulsive therapy (ECT).
Topics: Acute Disease; Anesthesia; Anesthesia, Inhalation; Anesthesia, Intravenous; Chronic Disease; Clinica | 1977 |
6 trials available for nitrous oxide and Chronic Disease
| Article | Year |
|---|---|
The Effect of Nitrous Oxide on the Outcomes of Underlay Tympanoplasty: A Prospective Study.
Topics: Adult; Anesthetics, Inhalation; Chronic Disease; Female; Hearing; Humans; Male; Myringoplasty; Nitro | 2019 |
Nitrous oxide anesthetic versus total intravenous anesthesia for functional endoscopic sinus surgery.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Chr | 2020 |
[Bronchial endoscopy under local anesthesia and pain in children. The value of a nitrous oxide-oxygen combination].
Topics: Adjuvants, Anesthesia; Administration, Rectal; Anesthesia, Local; Anesthetics, Inhalation; Anestheti | 1998 |
The effectiveness and safety of electroconvulsive therapy (ECT).
Topics: Acute Disease; Anesthesia; Anesthesia, Inhalation; Anesthesia, Intravenous; Chronic Disease; Clinica | 1977 |
Althesin and pancuronium in chronic liver disease.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Anesthesia, General; Chronic Disease; Humans; Liver D | 1975 |
Use of midazolam ('Dormicum') and flumazenil ('Anexate') in paediatric bronchology.
Topics: Anesthesia; Atropine; Bronchoscopy; Child, Preschool; Chronic Disease; Drug Administration Schedule; | 1992 |
20 other studies available for nitrous oxide and Chronic Disease
| Article | Year |
|---|---|
Another extensive nitrous oxide (N2O) myelopathy: The wood for the trees?
Topics: Chronic Disease; Humans; Inhalation Exposure; Magnetic Resonance Imaging; Male; Nitrous Oxide; Pares | 2020 |
Impact of ablation duration on rhythm outcome after concomitant maze procedure using cryoablation in patients with persistent atrial fibrillation.
Topics: Ablation Techniques; Atrial Fibrillation; Chronic Disease; Cryosurgery; Female; Humans; Male; Middle | 2017 |
Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
Topics: Adult; Biosensing Techniques; Chronic Disease; Cystic Fibrosis; Demography; Female; Humans; Male; Mi | 2014 |
Comparative activities of milk components in reversing chronic colitis.
Topics: Animals; Australia; Chronic Disease; Colitis; Colostrum; Cytokines; Dairy Products; Dextran Sulfate; | 2016 |
Starkey's compound oxygen as a hygienic for ailments chronic.
Topics: Analgesics, Non-Narcotic; Chronic Disease; History, 19th Century; Humans; Nitrous Oxide; Oxygen; Rho | 2013 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.
Topics: Anesthetics; Animals; Animals, Newborn; Apoptosis; Behavior, Animal; Brain; Chronic Disease; Drug Co | 2003 |
Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity?
Topics: Aged; Brain; Carbon Monoxide; Chronic Disease; Gait; Humans; Hypoxia; Magnetic Resonance Imaging; Ma | 2004 |
Pneumatosis cystoides intestinalis. Nitrous oxide anaesthesia and the rapid effect of oxygen therapy.
Topics: Anesthesia, Inhalation; Chronic Disease; Duodenal Ulcer; Humans; Intraoperative Complications; Male; | 1984 |
Middle ear effusions and the nitrous oxide myth.
Topics: Acoustic Impedance Tests; Adolescent; Anesthesia, Inhalation; Child; Child, Preschool; Chronic Disea | 1982 |
A comparison of the effects of morphine sulphate and nitrous oxide analgesia on chronic pain states in man.
Topics: Adult; Chronic Disease; Female; Humans; Male; Morphine; Naloxone; Nitrous Oxide; Pain, Intractable | 1981 |
[Various cytochemical reactions of the granulocytes in chronic experimental nitrous oxide poisoning and after neutralization with ammonia].
Topics: Acid Phosphatase; Alkaline Phosphatase; Ammonia; Animals; Antidotes; Azo Compounds; Chronic Disease; | 1980 |
[Morphometric examination of the adrenal glands in experimental chronic nitrous oxide poisoning and after neutralization with ammonia].
Topics: Adrenal Cortex; Adrenal Medulla; Ammonia; Animals; Antidotes; Chronic Disease; Guinea Pigs; Male; Ni | 1980 |
Gas exchange function through the mastoid mucosa in ears after surgery.
Topics: Adolescent; Adult; Child; Cholesteatoma, Middle Ear; Chronic Disease; Female; Gases; Humans; Male; M | 1997 |
[Changes in serum immunoglobulin levels in patients with chronic bronchitis exposed to nitrous oxide].
Topics: Adult; Air Pollutants, Occupational; Bronchitis; Chronic Disease; Dysgammaglobulinemia; Humans; IgA | 1988 |
[Clinico-physiological substantiation of using various methods of anesthesia in operations on the lungs in patients with chronic respiratory insufficiency].
Topics: Anesthesia, General; Chronic Disease; Ether; Fentanyl; Halothane; Hemodynamics; Humans; Lung Disease | 1985 |
Cryosurgery for the treatment of chronic rhinitis.
Topics: Chronic Disease; Cryosurgery; Denervation; Humans; Hypertrophy; Nasal Mucosa; Nitrous Oxide; Rhiniti | 1973 |
Risk of anesthesia and surgery in patients with chronic bronchitis and chronic obstructive pulmonary disease.
Topics: Adult; Age Factors; Aged; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Spinal; Anesthetics | 1973 |
[Therapy of coronary insufficiency with carbochromen].
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Circulation; Blood Pressure; Chronic Disease; Cor | 1970 |
The incidence of postoperative atelectasis in the dependent lung following thoracotomy: the value of added nitrogen.
Topics: Age Factors; Anesthesia, Inhalation; Bronchitis; Chronic Disease; Hernia, Diaphragmatic; Humans; Nit | 1970 |
The effects of halothane and atropine on total respiratory resistance in anesthetized man.
Topics: Adult; Aged; Airway Resistance; Anesthesia, General; Atropine; Bronchi; Bronchial Spasm; Chronic Dis | 1970 |